Inventor
Lothar Deurer
Inventor
Koblenz, DE
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61LMethods or apparatus for sterilising materials or objects in general13%
Y10TTechnical subjects covered by former us classification8%
A61FFilters implantable into blood vessels5%
B31DMaking articles of paper, cardboard or material worked in a manner analogous to paper, not provided for in subclasses b31b or b31c3%
B32BLayered products, i.e. products built-up of strata of flat or non-flat, e.g. cellular or honeycomb, form3%
B65CLabelling or tagging machines, apparatus, or processes3%
C07DHeterocyclic compounds3%
PatentTitleYear
9,616,045'Transdermal therapeutic system having improved long-term wearing comfort'20179,101,605'Buprenorphine transdermal therapeutic system and method of administering'20158,883,198'Transdermal rivastigmine therapeutic system'20148,628,795'Transdermal therapeutic buprenorphine system'20147,824,707'Transdermal therapeutic system provided with improved long-term carrying comfort'20107,384,651'Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience'20086,814,976'Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience'20046,558,696'Desoxypeganine'20036,315,854'Transdermal therapeutic plaster'20015,891,290'Method for the transfer of sections that are self-adhesive on one side from a moving first web onto a moving second web'19995,869,086'Systems for the controlled release of pilocarpine'19995,700,480'Transdermal therapeutic system comprising galanthamine as active component'19975,698,216'Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof'19975,681,413'Production of transdermal therapeutic systems'19975,240,711'Transdermal therapeutic system comprising as active component buprenorphine'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–2015Patents assigned to LOHMANN THERAPIE SYST LTS (14)· patent assignee history
1993–2017Based in Koblenz, DE· patent location history
1999Based in Kolbenz, DE· patent location history
2003Patents assigned to HF ARZNEIMITTELFORSCHUNG (1)· patent assignee history
2014Patents assigned to DEURER LOTHAR (2)· patent assignee history
2014Patents assigned to HILLE THOMAS (2)· patent assignee history
2017Patents assigned to LTS LOHMANN THERAPIE SYSTEME AG (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LOHMANN THERAPIE SYST LTS | 14 | 1993–2015 |
| DEURER LOTHARself | 2 | 2014 |
| HILLE THOMAS | 2 | 2014 |
| HF ARZNEIMITTELFORSCHUNG | 1 | 2003 |
| LTS LOHMANN THERAPIE SYSTEME AG | 1 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Koblenz, DE | 14 | 1993–2017 |
| Kolbenz, DE | 1 | 1999 |